Medtronic plc (NYSE: MDT)
Health Care · Health Care Equipment & Supplies · IE
$92.90
-0.48% today · +0.9% 1Y
Medtronic plc (NYSE: MDT) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $118.91B and employs 95,000 people.
Over the last twelve months the share price has gained 0.9%, trading between 73.31 and 106.33.
Tweenvest scores Medtronic plc across four factors: quality 80/100, value 65/100, growth 38/100, dividend 77/100. Its strongest factor is quality.
MDT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $118.91B
- Revenue (TTM)
- $36.36B
- P/E
- 24.91
- EPS
- 3.73
- Dividend yield
- 3.04%
- Beta (5Y)
- 0.57
- 52-week high
- $106.33
- 52-week low
- $73.31
- Avg volume (3M)
- —
- Shares outstanding
- 1.28B
- Employees
- 95,000
- Next earnings
- —
About Medtronic plc
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.
- ISIN
- IE00BTN1Y115
- Founded
- 1949
- Listed since
- May 2, 1973
- Exchange
- New York Stock Exchange
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.88B | $116.67 | +0.03% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.97B | $375.01 | +0.39% |
| Stryker CorporationNYSE: SYK | $125.74B | $327.81 | -0.50% |
| EssilorLuxottica Société anonymeENXTPA: EL | $86.72B | €160.35 | -0.83% |
| Boston Scientific CorporationNYSE: BSX | $71.03B | $49.01 | -2.70% |
| Siemens Healthineers AGXTRA: SHL | $52.46B | €40.06 | -0.82% |
| HOYA CorporationTSE: 7741 | $52.35B | ¥24,895.00 | -1.37% |
| Edwards Lifesciences CorporationNYSE: EW | $52.16B | $90.50 | +0.79% |
Figures last refreshed Aug 18, 2026.